Sotera Health Files 8-K on Financials
Ticker: SHC · Form: 8-K · Filed: Jan 14, 2025 · CIK: 1822479
| Field | Detail |
|---|---|
| Company | Sotera Health Co (SHC) |
| Form Type | 8-K |
| Filed Date | Jan 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, regulation-fd
TL;DR
Sotera Health dropped an 8-K detailing financial results and Reg FD disclosures.
AI Summary
Sotera Health Company filed an 8-K on January 14, 2025, reporting on its results of operations and financial condition. The filing also includes disclosures under Regulation FD and financial statements. The company is incorporated in Delaware and its principal executive offices are located in Broadview Heights, Ohio.
Why It Matters
This 8-K filing provides investors with crucial updates on Sotera Health's financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- Sotera Health Co (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 47-3531161 (tax_id) — IRS Employer Identification No.
- 9100 South Hills Blvd , Suite 300 Broadview Heights , Ohio 44147 (address) — Principal Executive Offices
- 440-262-1410 (phone_number) — Registrant's telephone number
- Sotera Health Topco, Inc. (company) — Former Company Name
- 20200824 (date) — Date of Former Company Name Change
- January 14, 2025 (date) — Date of Earliest Event Reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Sotera Health Company's results of operations and financial condition, as well as to provide disclosures under Regulation FD and include financial statements and exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on January 14, 2025.
Where are Sotera Health Company's principal executive offices located?
Sotera Health Company's principal executive offices are located at 9100 South Hills Blvd, Suite 300, Broadview Heights, Ohio 44147.
What was Sotera Health Company's former name?
Sotera Health Company's former name was Sotera Health Topco, Inc., and the name change occurred on August 24, 2020.
What is the company's state of incorporation?
Sotera Health Company is incorporated in Delaware.
Filing Stats: 682 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2025-01-14 07:35:05
Key Financial Figures
- $0.01 — ge on which registered Common stock, $0.01 par value per share SHC The Nasdaq Stoc
Filing Documents
- shc-20250114.htm (8-K) — 29KB
- january142025-ex991.htm (EX-99.1) — 19KB
- soterahealth_vxclrxrgbxrega.jpg (GRAPHIC) — 234KB
- 0001822479-25-000006.txt ( ) — 501KB
- shc-20250114.xsd (EX-101.SCH) — 2KB
- shc-20250114_lab.xml (EX-101.LAB) — 22KB
- shc-20250114_pre.xml (EX-101.PRE) — 13KB
- shc-20250114_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. The information under the heading "Preliminary Financial Results" under Item 7.01 is incorporated by reference into this Item 2.02.
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. Preliminary Financial Results On January 14, 2025, Sotera Health Company (the "Company") issued a press release announcing preliminary revenue results for full-year 2024 (the "Press Release"). A copy of the Press Release is attached hereto as Exhibit 99.1. These preliminary revenue results are based on information available to the Company as of January 14, 2025 and are subject to completion of the Company's year-end financial closing procedures and audit by the Company's independent registered public accounting firm. The range of revenues included in the Press Release is within the guidance provided at the time of the Company's third quarter earnings release. J.P. Morgan Healthcare Conference Presentation As previously announced, on January 7, 2025, Michael B. Petras, Jr., Chairman and CEO of the Company, will deliver a business update at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 at 11:15 a.m. Eastern Time. A copy of the Company's slide presentation and a link to the live presentation, or a replay of the webcast of the presentation, may be accessed via the Investor Relations section of the Company's website. The information in Item 2.02 and Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liability under that section, and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless expressly incorporated by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated January 14, 2025 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sotera Health Company (Registrant) Date: January 14, 2025 By: /s/ Jonathan M. Lyons Jonathan M. Lyons Senior Vice President and Chief Financial Officer